期刊文献+

高血压相关神经内分泌肿瘤:现状与进展 被引量:2

Neuroendocrine Neoplasias Related to Hypertension:Current Status and Progress
下载PDF
导出
摘要 神经内分泌肿瘤(neuroendocrine neoplasia,NEN)较罕见,部分NEN可分泌过量激素,引起患者血压升高,是继发性高血压的重要病因。导致高血压的NEN包括嗜铬细胞瘤/副神经节瘤、垂体生长激素瘤、垂体促肾上腺皮质激素瘤、甲状旁腺腺瘤/腺癌以及异位分泌激素的NEN。此类患者除高血压症状外,常伴有其他典型临床特征,但部分患者临床症状并不明显,需在早期加以识别。近年来,随着新的核素显像技术等应用于临床,极大提高了此类疾病的检出率,使更多患者得到及时诊治。 Neuroendocrine neoplasias(NENs) are rare. Some NENs secrete hormone, thus causing hypertension of the patients. NENs are important causes of secondary hypertension, which include pheochromocytoma and paraganglioma, growth hormone-secreting pituitary adenoma, adrenocorticotropic hormone-secreting pituitary adenoma, parathyroid adenoma and carcinoma, and ectopic hormone-secreting NENs. Apart from hypertension, most NEN patients had other typical clinical features that need to be identified at early stage. In recent years, with the application of new technologies of nuclide imaging, the detection rate of these diseases has been greatly improved, and more patients can be diagnosed and treated early.
作者 童安莉 李汉忠 TONG An-li;LI Han-zhong(Department of Endocrinology,Key Laboratory of Endocrinology,National Healh Commission of the People's Republic of China,Beijing 100730,China;Department of Urology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China)
出处 《协和医学杂志》 CSCD 2020年第4期361-364,共4页 Medical Journal of Peking Union Medical College Hospital
基金 中国医学科学院医学与健康科技创新工程(2017-12M-1-001)。
关键词 神经内分泌肿瘤 高血压 诊断 neuroendocrine neoplasia hypertension diagnosis
  • 相关文献

参考文献3

二级参考文献23

  • 1夏溟,李汉忠,刘广华,严维刚,袁铭,臧美孚.嗜铬细胞瘤术前准备的临床体会(附286例报告)[J].中华泌尿外科杂志,2004,25(12):816-818. 被引量:36
  • 2祝宇,王卫庆,沈永倩,吴瑜璇,张翀宇,芮文斌,周文龙,孙福康,刘定益,邵远,沈周俊,毕宇芳,苏颋为,姜蕾,宁光.嗜铬细胞瘤术前的高血压控制与术中高容量血液稀释[J].临床泌尿外科杂志,2006,21(8):571-573. 被引量:3
  • 3曾正陪.肾上腺髓质疾病[A].史轶蘩主编.协和内分泌和代谢学:第1版[C].北京:科学出版社,1999.1222-1244.
  • 4曾正陪.嗜铬细胞瘤.见:陈家伦,主编.临床内分泌学[M].上海:上海科学技术出版社,2011.63744.
  • 5Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2014,99 (6) : 1915-1942. DOI: 10. 1210/ jc. 2014-1498.
  • 6Shuch B, Ricketts C J, Metwalli AR, et al. The genetic basis of pheochromocytoma and paraganglioma: implications for management [ J ]. Urology, 2014, 83 ( 6 ) : 1225-1232. DOI: 10. 1016/j. urology. 2014.01. 007.
  • 7Dahia PL. Pheochromocytoma and paragang|ioma pathogenesis: learning from genetic heterogeneity [ J ]. Nat Rev Cancer, 2014, 14 (2) :108-119. DOI: 10. 1038/nrc3648.
  • 8D6nes J, Swords F, Rattenberry E, et al. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort [ J ]. J Clin Endocrinol Metab, 2015, 100 (3) : E531-541. DOI: 10. 1210/jc. 2014-3399.
  • 9Welander J, Andreasson A, Juhlin CC, et al. Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma [ J ]. J Clin Endocrinol Metab, 2014,99(7) :E1352-1360. DOI: 10. 1210/jc. 2013-4375.
  • 10Bravo EL, Gifford JR. Diagnosis. In: Manger WM, Gifford RW (eds). Clinical and Experimental Pheochromocytoma [ M ]. 2nd ed. Cambridge Mass: Blackwell Science, 1996. 205-332.

共引文献124

同被引文献6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部